What is Nanodropper?
Founded in 2017, Nanodropper has carved out a unique niche as the developer of the only FDA-listed, volume-reducing adaptor for eyedrop bottles. The core technology is designed to optimize medication delivery by reducing drop size to the precise volume the human eye can absorb, thereby minimizing waste and improving patient adherence to treatment regimens. This innovation is particularly relevant for patients managing chronic conditions such as glaucoma, where medication costs and delivery precision are paramount. By integrating seamlessly with existing bottle formats, the company provides a low-friction solution that addresses both economic and clinical challenges in modern ophthalmology.
How much funding has Nanodropper raised?
Nanodropper has raised a total of $1.4M across 1 funding round:
Angel/Seed
$1.4M
Angel/Seed (2021): $1.4M with participation from Rochester Area Chamber of Commerce, Alliance of Angels, and Golden Seeds
Key Investors in Nanodropper
Rochester Area Chamber of Commerce
A regional membership organization dedicated to fostering business success through advocacy, networking, and professional development, supporting local economic growth.
Alliance of Angels
Seattle’s premier network of angel investors, providing critical seed-stage financing and mentorship to high-growth startups across the Pacific Northwest.
Golden Seeds
A prominent venture capital firm focused on early-stage and growth capital investments, with a national presence and a commitment to fostering innovative startups.
What's next for Nanodropper?
With this major strategic investment, Nanodropper is well-positioned to scale its manufacturing capabilities and expand its distribution network across the United States. The company's roadmap likely involves deepening its clinical partnerships and exploring further iterations of its delivery technology to address broader medication administration challenges. As the firm moves into this next phase of growth, the focus will remain on solidifying its market position as a leader in patient-focused medical hardware, leveraging its recent financing to drive operational excellence and long-term value creation for stakeholders in the healthcare sector.
See full Nanodropper company page
